Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
carfilzomib (kyprolis) (3 trials)
pomalidomide (pomalyst) (1 trial)
urea (3 trials)
cyclophosphamide (cytoxan) (1 trial)
Amyloidosis (Phase 1)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (3 total)
Trial APIs (4 total)